MEDBRIEF HOLDINGS LIMITEDActive

Company number 09677162Private limited companyIncorporated 2015

Key figures

£299,556+63.4%
Net assets 2024/25
+155.4%
Average annual growth 2019/20–2024/25
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25

MEDBRIEF HOLDINGS LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25

Dividends

from the accounts
2024/25

Dividends paid in the financial year: £35,000 (15% of the profit for the year).

Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Profit for the year————232,008
Total assets128,095294,934347,378426,733—
Total liabilities71,006158,348244,444258,90548,368
Net assets / total equity48,145129,586112,584183,370299,556
Average number of employees33333
Dividends paid————35,000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MEDBRIEF HOLDINGS LIMITED

Company

MEDBRIEF HOLDINGS LIMITED is a private limited company registered with Companies House under company number 09677162. It was incorporated on 8 Jul 2015. Its status is active. The registered office is in Birmingham (B6). Its nature of business (SIC 2007) is web portals (63120).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Profit for the year was £232,008. Net assets were £299,556, up 63.4% on the previous year. The company had an average of 3 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

3 persons with significant control are registered. 1 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 21 Jul 2027.